A
Agnès Hartemann
Researcher at University of Paris
Publications - 81
Citations - 2368
Agnès Hartemann is an academic researcher from University of Paris. The author has contributed to research in topics: Diabetes mellitus & Type 2 diabetes. The author has an hindex of 21, co-authored 74 publications receiving 1817 citations. Previous affiliations of Agnès Hartemann include Institute of Chartered Accountants of Nigeria & French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012
Cécile Billionnet,Delphine Mitanchez,Alain Weill,Jacky Nizard,François Alla,Agnès Hartemann,S. Jacqueminet +6 more
TL;DR: GDM is associated with a moderately increased risk of adverse perinatal outcomes, which is higher in insulin-treated GDM than in non-insulin- treated GDM for most outcomes.
Journal ArticleDOI
Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
Agnès Hartemann,Gilbert Bensimon,Christine Payan,Sophie Jacqueminet,Olivier Bourron,Nathalie Nicolas,Michèle Fonfrède,Michelle Rosenzwajg,Claude C.A. Bernard,David Klatzmann +9 more
TL;DR: A well-tolerated and immunologically effective dose range of IL2 is defined for application to type 1 diabetes therapy and prevention, which could be relevant to other disorders in which a Treg cell increase would be desirable.
Journal ArticleDOI
Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients.
Michelle Rosenzwajg,Guillaume Churlaud,Roberto Mallone,Adrien Six,Nicolas Dérian,Wahiba Chaara,Roberta Lorenzon,S. Alice Long,Jane H. Buckner,Georgia Afonso,Hang-Phuong Pham,Agnès Hartemann,Aixin Yu,Alberto Pugliese,Thomas R. Malek,David Klatzmann +15 more
TL;DR: It is shown that low-dose interleukin-2 (ld-IL-2) safely expands/activates Tregs in patients with AID, such HCV-induced vasculitis and Type 1 Diabetes (T1D), and relevant for further development of ld- IL-2 for therapy and prevention of T1D, and other autoimmune and inflammatory diseases.
Journal ArticleDOI
A systematic review of interventions to enhance the healing of chronic ulcers of the foot in diabetes
Frances L. Game,Robert J. Hinchliffe,Jan Apelqvist,David G. Armstrong,K. Bakker,Agnès Hartemann,Magnus Löndahl,Patricia Elaine Price,William Jeffcoate +8 more
TL;DR: This working group has now updated this review by considering papers on the interventions to improve the healing of chronic ulcers published between December 2006 and June 2010.
Journal ArticleDOI
Chronic pain with neuropathic characteristics in diabetic patients: a French cross-sectional study.
TL;DR: The close correlation between the DN4 questionnaire and MNSI results suggests that screening tools for neuropathic pain could be used in daily practice for the identification of painful diabetic polyneuropathy.